The mechanism behind gallbladder issues with Ozempic involves two factors: slowed digestion and rapid weight loss
Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for type 2 diabetes management (Mounjaro) and chronic weight management (Zepbound)
And then, so the couple of questions that come to my mind is you know, I'm, I'm a, also a big believer, obviously it sounds like it's doing something, but I'm also a big believer that like nature has a very a method for its madness
In fact, we observed a decrease in GABA/Gln ratio for about 60% 3 h after ischemia (3IR) in the hippocampus, then in the cortex of about 50%, and the lowest change was detected in the cerebellum, of about 25%, which correlates with the proportion of observed compromised blood flow rate in 4VO model (Pulsinelli et al
Melber, A
Yes, numbers matter - especially to your clinician to start the conversation and for insurance to approve the prescription